Top Story

Coronavirus Covid Blue Social
COVID-19
Study launched on early intervention with immune modulators in COVID-19
A clinical trial has been launched to determine if there are benefits to early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness.
Featured
Dollar Money Coronavirus Mask Social
COVID-19
U.S. government investing $600M in COVID-19 test manufacturing
Sepsis Bacteria Social
Sepsis
Some emergency sepsis screening tools inadequate, EU study suggests
Latest News
Manufacturing Facility Process Social
Thermo Fisher Scientific prepared to expand its work at manufacturing facility
September 27, 2023
Vial Vaccine Vial Tech Social
HIV vaccine trial begins enrollment in U.S., South Africa
September 25, 2023
At-home or Lab-based STI testing/collection
Sponsored
At-home or Lab-based STI testing/collection
September 6, 2023
Business Graph Money Stocks Social
Invitae receives noncompliance notice from NYSE
September 25, 2023
Amyloid Plaque Alzheimer Social
Alzheimer's
Alzheimer’s drug approval poised to reshape APOE testing market
Stock
Invitae receives noncompliance notice from NYSE
Financing
Rome Therapeutics raises $72M in series B financing
Regulatory Guidance
NIH to require international collaborators to share all data
Kidney Social
Artificial Intelligence
AI model reveals kidney tumor features, potential for treatment response prediction
Breast Cancer
Consumer genetic testing may misrepresent breast cancer risk: Study
Financing
Rome Therapeutics raises $72M in series B financing
Informatics
Many British health trusts slow to adopt electronic records systems, shows BMJ survey
Coronavirus Covid Blue Social
COVID-19
Study launched on early intervention with immune modulators in COVID-19
COVID-19
U.S. government investing $600M in COVID-19 test manufacturing
Sepsis
Some emergency sepsis screening tools inadequate, EU study suggests
HIV
HIV vaccine trial begins enrollment in U.S., South Africa
More from LabPulse.com
AI model reveals kidney tumor features, potential for treatment response prediction
Researchers at the Dana-Farber Cancer Institute have trained artificial intelligence (AI) models to assess the clinical features of kidney cancer tumor samples to predict how tumors may respond to immune therapy.
September 22, 2023
Kidney Social
Consumer genetic testing may misrepresent breast cancer risk: Study
Women are being told they are at high risk of breast cancer from consumer genetic test results which do not take family history into account, say researchers.
September 21, 2023
Breast Cancer3 Social
Rome Therapeutics raises $72M in series B financing
Biotech company Rome Therapeutics has raised a further $72 million in financing to develop medicines for autoimmune diseases and continue its exploration of the “dark genome.”
September 20, 2023
Dna Genome Gene Targeted Social
NIH to require international collaborators to share all data
Despite concerns from researchers and organizations, the U.S. National Institutes of Health (NIH) will implement its new mandate requiring foreign partners to share raw data and notebooks at regular set intervals with their primary U.S. grant recipients.
September 22, 2023
Lab Scientists Social
Many British health trusts slow to adopt electronic records systems, shows BMJ survey
Many health organizations in England are still reliant on paper patient notes and drug charts, despite progress toward electronic records and prescribing, The BMJ has found.
September 22, 2023
Doctor Fills Patient Medical Record Social
Danaher cuts cost of rapid TB test after years of pressure from activists
Danaher has cut the cost of one of its tuberculosis (TB) tests in less developed countries after years of public pressure to lower the price.
September 21, 2023
Bacteria Mycobacterium Tuberculosis Social
Protein biomarker may aid in early Parkinsonian disorders detection
A protein biomarker present in cerebrospinal fluid and blood plasma may be useful for the early diagnosis of Parkinsonian disorders.
September 21, 2023
Parkinsons Lewy Bodies Social
Day Zero Diagnostics completes $16M financing round
Day Zero Diagnostics has completed a $16 million financing round, executed as a convertible note.
September 20, 2023
Research Money Social
Polygenic risk scores from multi-ancestry GWASs more accurate in diverse groups: Study
Polygenic risk scores (PRS) derived from multi-ancestry genome-wide association studies (GWASs) outperform PRSs based on single-ancestry GWASs in underrepresented populations, new research shows.
September 21, 2023
Genome Sequence Barcode Social
Researchers develop signature for scoring thyroid cancers
A team led by researchers at Vanderbilt University Medical Center has developed a signature for thyroid cancer aggressiveness that incorporates immune and other microenvironment features through multiomic analyses.
September 20, 2023
Thyroid Social
NIH starts early-phase trial of second-generation universal flu vaccine candidate
The U.S. National Institutes of Health (NIH) has begun an early-phase clinical trial of its second-generation universal flu vaccine candidate.
September 20, 2023
Needle Shot Vaccine Teenager Social
Broken String Biosciences raises $15M in series A financing round
Broken String Biosciences has closed a $15 million series A financing round.
September 19, 2023
Dna Sequence Shadow Social